C Tong, Y Zhang, Y Liu, X Ji, W Zhang… - Blood, The Journal …, 2020 - ashpublications.org
Chimeric antigen receptor (CAR) T cells targeting CD19 have achieved breakthroughs in the
treatment of hematological malignancies, such as relapsed/refractory non-Hodgkin …